Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLOROTIC: Hydrochlorothiazide in Decompensated Heart Failure
NCT01647932Phase 3Completed
- Sponsor
- Sociedad Española de Medicina Interna
- Start
- Oct 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrochlorothiazide in heart failure (HF), sponsored by Sociedad Española de Medicina Interna. Started Oct 2014; status: completed.
02
Drugs
hydrochlorothiazide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01647932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01647932.